Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015...

Sharon Bio-Medicine Limited operates as a pharmaceutical company. The Company focuses on developing and manufacturing pharmaceutical intermediates, actives, and finished dosages. Sharon Bio-Medicine aims to develops generic alternatives for new drugs.

Trading Window

SHARONBIO: The Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 18-Feb-2023, regarding strikes/lockouts/disturbances. On basis of above the Company was required to clarify following: 1. In...

Reply to Clarification Sought

Sharon Bio-Medicine Limited has informed the Exchange regarding ''...

Updates

SHARONBIO: The Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 18-Feb-2023, regarding strikes/lockouts/disturbances. On basis of above the Company is required to clarify following: 1. In...

Clarification

Sharon Bio-Medicine Limited has informed the Exchange about strikes/lockouts/disturbances...

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sharon Bio-Medicine (SBML IN)

Trading Window

Reply to Clarification Sought

Updates

Clarification

Strikes/Lockouts/Disturbances

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)